全文获取类型
收费全文 | 877篇 |
免费 | 86篇 |
国内免费 | 40篇 |
出版年
2023年 | 7篇 |
2022年 | 22篇 |
2021年 | 40篇 |
2020年 | 22篇 |
2019年 | 28篇 |
2018年 | 23篇 |
2017年 | 15篇 |
2016年 | 28篇 |
2015年 | 44篇 |
2014年 | 63篇 |
2013年 | 77篇 |
2012年 | 74篇 |
2011年 | 76篇 |
2010年 | 48篇 |
2009年 | 30篇 |
2008年 | 36篇 |
2007年 | 39篇 |
2006年 | 38篇 |
2005年 | 31篇 |
2004年 | 23篇 |
2003年 | 25篇 |
2002年 | 13篇 |
2001年 | 17篇 |
2000年 | 13篇 |
1999年 | 19篇 |
1998年 | 10篇 |
1997年 | 8篇 |
1996年 | 5篇 |
1995年 | 11篇 |
1994年 | 3篇 |
1992年 | 10篇 |
1991年 | 5篇 |
1990年 | 5篇 |
1989年 | 6篇 |
1988年 | 6篇 |
1987年 | 4篇 |
1986年 | 9篇 |
1985年 | 7篇 |
1984年 | 6篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1979年 | 5篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1975年 | 3篇 |
1972年 | 5篇 |
1969年 | 4篇 |
1968年 | 3篇 |
1967年 | 4篇 |
1963年 | 2篇 |
排序方式: 共有1003条查询结果,搜索用时 15 毫秒
101.
Liao P Yu D Li G Yong TF Soon JL Chua YL Soong TW 《The Journal of biological chemistry》2007,282(48):35133-35142
Native smooth muscle L-type Ca(v)1.2 calcium channels have been shown to support a fraction of Ca(2+) currents with a window current that is close to resting potential. The smooth muscle L-type Ca(2+) channels are also more susceptible to inhibition by dihydropyridines (DHPs) than the cardiac channels. It was hypothesized that smooth muscle Ca(v)1.2 channels exhibiting hyperpolarized shift in steady-state inactivation would contribute to larger inhibition by DHP, in addition to structural differences of the channels generated by alternative splicing that modulate DHP sensitivities. In addition, it has also been shown that alternative splicing modulates DHP sensitivities by generating structural differences in the Ca(v)1.2 channels. Here, we report a smooth muscle L-type Ca(v)1.2 calcium channel splice variant, Ca(v)1.2SM (1/8/9(*)/32/Delta33), that when expressed in HEK 293 cells display hyperpolarized shifts for steady-state inactivation and activation potentials when compared with the established Ca(v)1.2b clone (1/8/9(*)/32/33). This variant activates from more negative potentials and generates a window current closer to resting membrane potential. We also identified the predominant cardiac isoform Ca(v)1.2CM clone (1a/8a/Delta9(*)/32/33) that is different from the established Ca(v)1.2a (1a/8a/Delta9(*)/31/33). Importantly, Ca(v)1.2SM channels were shown to be more sensitive to nifedipine blockade than Ca(v)1.2b and cardiac Ca(v)1.2CM channels when currents were recorded in either 5 mM Ba(2+) or 1.8 mM Ca(2+) external solutions. This is the first time that a smooth muscle Ca(v)1.2 splice variant has been identified functionally to possess biophysical property that can be linked to enhanced state-dependent block by DHP. 相似文献
102.
Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo 总被引:2,自引:0,他引:2
Mitofusin-2 (Mfn2) suppresses smooth muscle cell proliferation through inhibition of the Ras-extracellular signal-regulated kinases (ERK1/2) pathway. Since the ERK1/2 pathway is implicated in mediating hypertrophic signaling, we studied the changes in Mfn2 in cardiac hypertrophy using in vitro and in vivo models. Phenylephrine was used to induce hypertrophy in neonatal rat ventricular myocytes (NRVMs). In vivo hypertrophy models included spontaneously hypertensive rats (SHR), pressure-overload hypertrophy by transverse aortic constriction (TAC), hypertrophy of non-infarcted myocardium following myocardial infarction (MI), and cardiomyopathy due to cardiac-restricted overexpression of beta(2)-adrenergic receptors (beta(2)-TG). We determined hypertrophic parameters and analysed expression of atrial natriuretic peptide (ANP) and Mfn2 by real-time PCR. Phosphorylated-ERK1/2 (phospho-ERK) was measured by Western blot. Mfn2 was downregulated in phenylephrine treated NRCMs (by approximately 40%), hypertrophied hearts from SHR (by approximately 80%), mice with TAC (at 1 and 3 weeks, by approximately 50%), and beta(2)-TG mice (by approximately 20%). However, Mfn2 was not downregulated in hypertrophied hearts with 15 weeks of TAC, nor in hypertrophied non-infarcted myocardium following MI. phospho-ERK1/2 was increased in hypertrophied myocardium at 1 week post-TAC, but not in non-infarcted myocardium after MI, indicating that downregulated Mfn2 may be accompanied by an increase of phospho-ERK1/2. This study shows, for the first time, downregulated Mfn2 expression in hypertrophied hearts, which depends on the etiology and time course of hypertrophy. Further study is required to examine the causal relationship between Mfn2 and cardiac hypertrophy. 相似文献
103.
104.
Zhi Liu Esther C. Leng Kannan Gunasekaran Martin Pentony Min Shen Monique Howard Janelle Stoops Kathy Manchulenko Vladimir Razinkov Hua Liu William Fanslow Zhonghua Hu Nancy Sun Haruki Hasegawa Rutilio Clark Ian N. Foltz Wei Yan 《The Journal of biological chemistry》2015,290(12):7535-7562
Producing pure and well behaved bispecific antibodies (bsAbs) on a large scale for preclinical and clinical testing is a challenging task. Here, we describe a new strategy for making monovalent bispecific heterodimeric IgG antibodies in mammalian cells. We applied an electrostatic steering mechanism to engineer antibody light chain-heavy chain (LC-HC) interface residues in such a way that each LC strongly favors its cognate HC when two different HCs and two different LCs are co-expressed in the same cell to assemble a functional bispecific antibody. We produced heterodimeric IgGs from transiently and stably transfected mammalian cells. The engineered heterodimeric IgG molecules maintain the overall IgG structure with correct LC-HC pairings, bind to two different antigens with comparable affinity when compared with their parental antibodies, and retain the functionality of parental antibodies in biological assays. In addition, the bispecific heterodimeric IgG derived from anti-HER2 and anti-EGF receptor (EGFR) antibody was shown to induce a higher level of receptor internalization than the combination of two parental antibodies. Mouse xenograft BxPC-3, Panc-1, and Calu-3 human tumor models showed that the heterodimeric IgGs strongly inhibited tumor growth. The described approach can be used to generate tools from two pre-existent antibodies and explore the potential of bispecific antibodies. The asymmetrically engineered Fc variants for antibody-dependent cellular cytotoxicity enhancement could be embedded in monovalent bispecific heterodimeric IgG to make best-in-class therapeutic antibodies. 相似文献
105.
This study was undertaken to compare the chemical properties and yields of pineapple leaf residue (PLR) char produced by field burning (CF) with that produced by a partial combustion of air-dried PLR at 340 °C for 3 h in a furnace (CL). Higher total C, lignin content, and yield from CL as well as the presence of aromatic compounds in the Fourier Transform Infrared spectra of the char produced from CL suggest that the CL process was better in sequestering C than was the CF process. Although the C/N ratio of char produced from CL was low indicating a high N content of the char, the C in the char produced from CL was dominated by lignin suggesting that the decomposition of char produced from CL would be slow. To sequester C by char application, the PLR should be combusted in a controlled process rather than by burning in the field. 相似文献
106.
Predicting the wetland distributions under climate warming in the Great Xing’an Mountains,northeastern China 总被引:1,自引:0,他引:1
Hongjuan Liu Rencang Bu Jintong Liu Wenfang Leng Yuanman Hu Libing Yang Huitao Liu 《Ecological Research》2011,26(3):605-613
The wetland ecosystem is particularly vulnerable to hydrological and climate changes. The Great Xing’an Mountain is such a
region in China that has a large area of wetlands with rare human disturbance. The predictions of the global circulation model
CGCM3 (the third-generation coupled global climate model from the Canadian Centre for Climate Modeling and Analysis) indicated
that the temperature in The Great Xing’an Mountain will rise by 2–4°C over the next 100 years. This paper predicts the potential
distributions of wetlands in this area under the current and warming climate conditions. This predication was performed by
the Random Forests model, with 18 environmental variables, which will reflect the climate and topography conditions. The model
has been proven to have a great prediction ability. The wetland distributions are primarily topography-driven in the Great
Xing’an Mountains. Mean annual temperature, warmness index, and potential evapotranspiration ratio are the most important
climatic factors in wetland distributions. The model predictions for three future climate scenarios show that the wetland
area tends to decrease, and higher emission will also cause more drastic shrinkage of wetland distributions. About 30% of
the wetland area will disappear by 2050. The area will decrease 62.47, 76.90, and 85.83%, respectively, under CGCM3-B1, CGCM3-A1B,
and CGCM3-A2 by 2100. As for spatial allocation, wetlands may begin to disappear from the sides to the center and south to
north under a warming climate. Under CGCM3-B1, the loss of wetlands may mainly occur in the south hills with flatter terrain,
and some may occur in the north hills and intermontane plains. Under CGCM3-A1B, severe vanish of wetlands is predicted. Under
CGCM3-A2, only a small area of wetlands may remain in the north of the high mountains. 相似文献
107.
The genetic differentiation of populations is a key parameter in population genetic investigations. Wright's F(ST) (and its relatives such as G(ST) ) has been a standard measure of differentiation. However, the deficiencies of these indexes have been increasingly realized in recent years, leading to some new measures being proposed, such as Jost's D (Molecular Ecology, 2008; 17, 4015). The existence of these new metrics has stimulated considerable debate and induced some confusion on which statistics should be used for estimating population differentiation. Here, we report a simulation study with neutral microsatellite DNA loci under a finite island model to compare the performance of G(ST) and D, particularly under nonequilibrium conditions. Our results suggest that there exist fundamental differences between the two statistics, and neither G(ST) nor D operates satisfactorily in all situations for quantifying differentiation. D is very sensitive to mutation models but G(ST) noticeably less so, which limits D's utility in population parameter estimation and comparisons across genetic markers. Also, the initial heterozygosity of the starting populations has some important effects on both the individual behaviours of G(ST) and D and their relative behaviours in early differentiation, and this effect is much greater for D than G(ST) . In the early stages of differentiation, when initial heterozygosity is relatively low (<0.5, if the number of subpopulations is large), G(ST) increases faster than D; the opposite is true when initial heterozygosity is high. Therefore, the state of the ancestral population appears to have some lasting impacts on population differentiation. In general, G(ST) can measure differentiation fairly well when heterozygosity is low whatever the causes; however, when heterozygosity is high (e.g. as a result of either high mutation rate or high initial heterozygosity) and gene flow is moderate to strong, G(ST) fails to measure differentiation. Interestingly, when population size is not very small (e.g. N ≥ 1000), G(ST) measures differentiation quite linearly with time over a long duration when gene flow is absent or very weak even if mutation rate is not low (e.g. μ = 0.001). In contrast, D, as a differentiation measure, performs rather robustly in all these situations. In practice, both indexes should be calculated and the relative levels of heterozygosities (especially H(S) ) and gene flow taken into account. We suggest that a comparison of the two indexes can generate useful insights into the evolutionary processes that influence population differentiation. 相似文献
108.
Although MDM2 is known to be a critical negative regulator of p53, MDM2 only catalyzes p53 mono- or multiple monoubiquitination in vitro and in vivo, which is insufficient for the initiation of proteasomal degradation. MDM2 does not polyubiquitinate p53 in vitro, however, which indicates that the activity of other ubiquitin ligase(s) or cofactor(s) is required for MDM2-mediated p53 polyubiquitination and degradation. In our recent study, we demonstrated that UBE4B, an E3 and E4 ubiquitin ligase with a U-box domain, interacts physically with both p53 and MDM2. Our findings revealed that UBE4B negatively regulates the level of p53 and inhibits p53-dependent transactivation and apoptosis. We propose that inhibition of MDM2 binding to UBE4B may provide another approach to inhibit MDM2 E3 ligase activity for tumor suppressor p53. It could lead to novel anticancer therapies, with the possibility of reducing the public health burden from cancer.Key words: ubiquitination, MDM2, UBE4B, p53, degradation 相似文献
109.
Wu H Pomeroy SL Ferreira M Teider N Mariani J Nakayama KI Hatakeyama S Tron VA Saltibus LF Spyracopoulos L Leng RP 《Nature medicine》2011,17(3):347-355
The TP53 gene (encoding the p53 tumor suppressor) is rarely mutated, although frequently inactivated, in medulloblastoma and ependymoma. Recent work in mouse models showed that the loss of p53 accelerated the development of medulloblastoma. The mechanism underlying p53 inactivation in human brain tumors is not completely understood. We show that ubiquitination factor E4B (UBE4B), an E3 and E4 ubiquitin ligase, physically interacts with p53 and Hdm2 (also known as Mdm2 in mice). UBE4B promotes p53 polyubiquitination and degradation and inhibits p53-dependent transactivation and apoptosis. Notably, silencing UBE4B expression impairs xenotransplanted tumor growth in a p53-dependent manner and overexpression of UBE4B correlates with decreased expression of p53 in these tumors. We also show that UBE4B overexpression is often associated with amplification of its gene in human brain tumors. Our data indicate that amplification and overexpression of UBE4B represent previously undescribed molecular mechanisms of inactivation of p53 in brain tumors. 相似文献
110.
Recurrent intracranial aneurysms can occur after either surgical clipping or endovascular therapy. In this article, we present
a consecutive series of 18 patients who underwent individual treatment for recurrent aneurysms after primary coil embolization
or surgical clipping. During an 8-year period between May 1997 and December 2005, 18 patients underwent individual treatment
for recurrent aneurysms. Clinical data and imaging studies of the patients were analyzed retrospectively. Out of the 18 patients,
13 had recurrent aneurysms located in the anterior circulation, and 5 had aneurysms of the posterior circulation. Treatment
consisted of coiling in 16 patients and clipping in two patients. Of the 18 patients, 15 achieved a good or excellent recovery,
two were paralyzed, and one died post-treatment. Both the surgical clipping and endovascular embolization for the treatment
of recurrent intracranial aneurysms can achieve very good radiological results with low mortality rates. One of the key points
for the successful treatment of this kind of lesions is the proper, individual, and interdisciplinary patient selection. 相似文献